Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study

被引：6

作者：

Shady, Nourhan Hisham ^{[1
]}

Hayallah, Alaa M. ^{[2
,3
]}

Mohamed, Mamdouh F. A. ^{[4
]}

Ghoneim, Mohammed M. ^{[5
,6
]}

Chilingaryan, Garri ^{[7
,8
]}

Al-Sanea, Mohammad M. ^{[9
]}

Fouad, Mostafa A. ^{[10
]}

Kamel, Mohamed Salah ^{[1
,10
]}

Abdelmohsen, Usama Ramadan ^{[1
,10
]}

机构：

[1] Deraya Univ, Fac Pharm, Dept Pharmacognosy, New Minia City 61111, Egypt

[2] Assiut Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Assiut 71526, Egypt

[3] Sphinx Univ, Fac Pharm, Pharmaceut Chem Dept, New Assiut 71515, Egypt

[4] Sohag Univ, Fac Pharm, Dept Pharmaceut Chem, Sohag 82524, Egypt

[5] AlMaarefa Univ, Coll Pharm, Dept Pharm Practice, Ad Diriyah 13713, Saudi Arabia

[6] Al Azhar Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11371, Egypt

[7] NAS RA, Inst Mol Biol, Yerevan 0014, Armenia

[8] Russian Armenian Univ, Inst Biomed & Pharm, Yerevan 0051, Armenia

[9] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Aljouf 72341, Saudi Arabia

[10] Minia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya 61519, Egypt

来源：

MOLECULES | 2021年 / 26卷 / 12期

关键词：

COVID-19; coronavirus; molecular docking; Amphimedon sp; sponge; ANTICANCER ACTIVITY; NATURAL-PRODUCTS; INHIBITORS; DESIGN; PROTEASE;

D O I：

10.3390/molecules26123775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Since December 2019, novel coronavirus disease 2019 (COVID-19) pandemic has caused tremendous economic loss and serious health problems worldwide. In this study, we investigated 14 natural compounds isolated from Amphimedon sp. via a molecular docking study, to examine their ability to act as anti-COVID-19 agents. Moreover, the pharmacokinetic properties of the most promising compounds were studied. The docking study showed that virtually screened compounds were effective against the new coronavirus via dual inhibition of SARS-CoV-2 RdRp and the 3CL main protease. In particular, nakinadine B (1), 20-hepacosenoic acid (11) and amphimedoside C (12) were the most promising compounds, as they demonstrated good interactions with the pockets of both enzymes. Based on the analysis of the molecular docking results, compounds 1 and 12 were selected for molecular dynamics simulation studies. Our results showed Amphimedon sp. to be a rich source for anti-COVID-19 metabolites.

引用

页数：15

共 50 条

[41] Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV-2
Guma, Samuel Desta
Zhou, Zhaoyin
Song, Kang
Yang, Feipu
Suo, Jin
Zhang, Yan
Bonku, Emmanuel Mintah
Odilov, Abdullajon
Tian, Guanghui
Xu, Zhijian
Jiang, Xiangrui
Zhang, Qiumeng
Zhu, Weiliang
Shen, Jingshan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 281
[42] A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors
Mathieu, Cyrille
Touret, Franck
Jacquemin, Clemence
Janin, Yves L.
Nougairede, Antoine
Brailly, Manon
Mazelier, Magalie
Decimo, Didier
Vasseur, Virginie
Hans, Aymeric
Valle-Casuso, Jose-Carlos
de Lamballerie, Xavier
Horvat, Branka
Andre, Patrice
Si-Tahar, Mustapha
Lotteau, Vincent
Vidalain, Pierre-Olivier
VIRUSES-BASEL, 2021, 13 (09):
[43] In Silico Molecular Docking and Molecular Dynamic Simulation Analysis of Phytochemicals From Indian Foods as Potential Inhibitors of SARS-CoV-2 RdRp and 3CLpro
Qazi, Sahar
Das, Soumi
Khuntia, Bharat Krushna
Sharma, Vandna
Sharma, Shruti
Sharma, Gautam
Raza, Khalid
NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (09)
[44] Integrating virtual screening, pharmacoinformatics profiling, and molecular dynamics: identification of promising inhibitors targeting 3CLpro of SARS-CoV-2
Mohammad, Abeer
Zheoat, Ahmed
Oraibi, Amjad
Manaithiya, Ajay
Almaary, Khalid S.
Nafidi, Hiba Allah
Bourhia, Mohammed
Kilani-Jaziri, Soumaya
Bin Jardan, Yousef A.
FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 10
[45] Bayesian Inference Elucidates the Catalytic Competency of the SARS-CoV-2 Main Protease 3CLpro
Wralstad, Evans C.
Sayers, Jessica
Raines, Ronald T.
ANALYTICAL CHEMISTRY, 2023, 95 (40) : 14981 - 14989
[46] Cys44 of SARS-CoV-2 3CLpro affects its catalytic activity
Iacobucci, Ilaria
Cipollone, Irene
Cozzolino, Flora
Iaconis, Daniela
Talarico, Carmine
Coppola, Gabriele
Morasso, Stefano
Costanzi, Elisa
Malune, Paolo
Storici, Paola
Tramontano, Enzo
Esposito, Francesca
Monti, Maria
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 295
[47] Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors
Stille, Julia K. K.
Tjutrins, Jevgenijs
Wang, Guanyu
Venegas, Felipe A. A.
Hennecker, Christopher
Rueda, Andres M.
Sharon, Itai
Blaine, Nicole
Miron, Caitlin E.
Pinus, Sharon
Labarre, Anne
Plescia, Jessica
Patrascu, Mihai Burai
Zhang, Xiaocong
Wahba, Alexander S.
Vlaho, Danielle
Huot, Mitchell J.
Schmeing, T. Martin
Mittermaier, Anthony K. K.
Moitessier, Nicolas
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
[48] Design and synthesis of diphenyl-1H-imidazole analogs targeting Mpro/3CLpro enzyme of SARS-CoV-2
Kanhed, Ashish M.
Vora, Amisha
Thakkar, Ami
Rudramurthy, Gudepalya Renukaiah
Shandil, Radha Krishan
Harisha, Rajappa
Singh, Mayas
Narayanan, Shridhar
MEDICINAL CHEMISTRY RESEARCH, 2024, 33 (09) : 1568 - 1577
[49] Molecular Dynamics Simulation of Privileged Biflavonoids as SARS-CoV2 3CLpro Targeting Agents
Vahabzadeh, Taha
Miran, Mansour
Razzaghi-Asl, Nima
JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2022, 21 (05): : 569 - 582
[50] Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro
Wang, Ruyu
Hu, Qing
Wang, Haonan
Zhu, Guanghao
Wang, Mengge
Zhang, Qian
Zhao, Yishu
Li, Chunyu
Zhang, Yani
Ge, Guangbo
Chen, Hongzhuan
Chen, Lili
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 183 : 182 - 192

← 1 2 3 4 5 →